Various immune and tissue cells via multiple adhesion and co-stimulatory molecules

The phrase Various immune and tissue cells via multiple adhesion and co-stimulatory molecules refers to a broad biological system rather than a single molecular target. This system involves the interaction of leukocytes with other cells through adhesion molecules, such as integrins and selectins, and co-stimulatory receptors like CD28 and CD80/CD86 (Source: PubMed, PMID: 17186029). These interactions are fundamental for the recruitment of immune cells to sites of injury and the regulation of T-cell activation and survival (Source: Janeway's Immunobiology). In many autoimmune and inflammatory diseases, these pathways are dysregulated, leading to persistent immune-mediated tissue damage. Therapeutic strategies often target specific components of this system, such as the use of abatacept to block co-stimulation or vedolizumab to inhibit tissue-specific adhesion (Source: FDA Label for Orencia and Entyvio). Because this term describes a collective mechanism involving numerous distinct proteins and cell types, it is not classified as a specific therapeutic target in a structured pharmacological context. Instead, it serves as a descriptive summary of the complex cellular and molecular crosstalk that governs immune responses.

Other names

Cell adhesion molecules (CAMs)Co-stimulatory receptorsImmune checkpoint moleculesLeukocyte-endothelial interactions

Modulation of immune cell activation and trafficking by blocking or stimulating adhesion and co-stimulatory pathways.